[1]
“THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE”, ICMS, vol. 2, no. 10, p. 79, Oct. 2024, Accessed: Nov. 21, 2024. [Online]. Available: https://mjstjournal.com/index.php/icms/article/view/1975